Sentences with phrase «vaccines use viral»

Not exact matches

Today all new viral strains used to make vaccines must be generated by specific artificial genetic modifications rather than by «breeding,» so as to prevent possible reversion back to a virulent form.

Yet the 57 - year - old health minister insisted she had cause: Rich Western nations were patenting the viral genomes, then using the information to create vaccines that were sold for profit to other Western powers while benefiting Indonesia not at all.

Some newer vaccine candidates use harmless viruses such as modified adenoviruses to deliver genes that encode immunizing viral proteins.

By contrast, the new Zika candidate vaccine uses tiny strands of RNA that hold the genetic codes for making viral proteins.

This vaccine uses an inactive herpes virus (stripped of its viral genes) to transport a small amount of Aß as well as another protein called interleukin - 4 that may help prevent brain inflammation.

Historically, vaccines against viral diseases have used live - attenuated (weakened) viruses or inactivated whole viruses to induce protective immune responses.

There are currently no vaccines or drugs approved for human use and no post-exposure treatment that has completely protected nonhuman primates against MARV - Angola, the most deadly Marburg viral strain, with a mortality rate of up to 90 percent.

Kang's primary research focuses on designing and developing effective vaccines against viral diseases such as influenza virus and RSV, but he partnered with a university and research institutes in South Korea that wanted international collaborative projects to study if ginseng can be used to improve health and protect against disease because of the potential benefit in fighting these viruses.

Chicken farmers in Australia were using two live vaccines, both made from Australian viral strains, against a poultry disease called infectious laryngotracheitis (ILT).

Then the agency will select for these viral strains and use them for future vaccines.

The DNA vaccine also is safer because it does not use attenuated viruses to produce viral antigens.

Identification of optimal vaccine formulations and administration routes for the induction of CD8 + T - cell responses (SSI): The induction of suitable CD8 + T - cell responses following vaccination usually requires the use of live viral vectors.

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), helped identify the viral strain used in the ZPIV vaccine, supported the preclinical safety testing, and is sponsoring the conduct of this trial.

We carry out translational research programmes to develop infectious disease vaccines, therapeutics and diagnostics using animal models of tuberculosis, influenza, HIV / AIDS, Clostridium difficile, meningococcal disease, chlamydia, burkholderia and anthrax, as well as emerging viral diseases such as Crimean Congo haemorrhagic fever.

• RV217 (ECHO): HIV - 1 Prevalence, Incidence, Cohort Retention, and Host Genetics and Viral Diversity in High Risk Cohorts in East Africa • Infectious Disease Surveillance (HIV, TB and Malaria) and Cohort Development Among Urban and Rural Communities • Karolinska Institute vaccine study in Tanzania testing a prime - boost HIV vaccine regimen using unadjuvanted DNA vaccines followed by a Modified Vaccinia Ankara (MVA), which was developed by MHRP and NIAID.

Preclinical studies of vaccine candidates have typically shown post-infection virologic control, but protection against acquisition of infection has previously only been reported using less rigorous viral challenges.

Recent attempts on extensive trials of cancer vaccines, using viral structures or substructures against several cancers such as cervices, prostate, lung, pancreatic and skin also failed to produce the overall protective clinical outcomes

To generate the vaccine we modified the viral non-structural protein 1 (NS1) using a genetic engineering technique known as reverse genetics.

The most commonly used vaccine against panleukopenia, herpesvirus and calicivirus is a multivalent vaccine: it contains viral antigens for several diseases together in the same dose, and is commonly abbreviated as the «FVRCP» vaccine.